Compounds > du-21220
Page last updated: 2024-08-23

du-21220 and scopolamine hydrobromide

du-21220 has been researched along with scopolamine hydrobromide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Lombardo, F; Obach, RS; Waters, NJ1
Okun, R1

Other Studies

3 other study(ies) available for du-21220 and scopolamine hydrobromide

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
New medications-1981.
    Annual review of pharmacology and toxicology, 1981, Volume: 21

    Topics: Administration, Topical; Adrenal Gland Neoplasms; alpha-Methyltyrosine; Antiviral Agents; Daunorubicin; Drug Therapy; Epinephrine; Glaucoma; Humans; Methyltyrosines; Minoxidil; Oxamniquine; Pheochromocytoma; Ritodrine; Scopolamine; Trifluridine

1981